Compare PTCT & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | SSRM |
|---|---|---|
| Founded | 1998 | 1946 |
| Country | United States | United States |
| Employees | N/A | 2900 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.4B |
| IPO Year | 2006 | N/A |
| Metric | PTCT | SSRM |
|---|---|---|
| Price | $76.82 | $26.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 4 |
| Target Price | ★ $80.65 | $32.74 |
| AVG Volume (30 Days) | 1.5M | ★ 2.9M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 264.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $56.48 |
| Revenue Next Year | $17.70 | $4.31 |
| P/E Ratio | ★ N/A | $14.37 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $43.18 | $11.87 |
| 52 Week High | $90.87 | $36.52 |
| Indicator | PTCT | SSRM |
|---|---|---|
| Relative Strength Index (RSI) | 43.24 | 44.94 |
| Support Level | $74.45 | $24.80 |
| Resistance Level | $79.67 | $28.81 |
| Average True Range (ATR) | 3.27 | 1.28 |
| MACD | -1.01 | -0.05 |
| Stochastic Oscillator | 4.47 | 33.67 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.